StockData
VASOOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

VASO Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.29+0.00 (+0.06%)

Close on Oct 19, 2026

Market cap
$51.17M
P/E (TTM)
29.0
Dividend yield
–

About VASO

Electromedical & Electrotherapeutic Apparatus, SIC 3845

Vaso Corporation operates in the healthcare equipment and information technology sectors through three business segments. Its IT segment provides managed network infrastructure, transport, and network security services. The professional sales service segment serves as an exclusive representative selling GE HealthCare diagnostic imaging equipment, ultrasound systems, service contracts, and training to healthcare providers in the middle market. Its medical equipment segment designs, manufactures, and services cardiovascular diagnostic and therapeutic products. These offerings include ambulatory blood pressure and ECG monitors, physiological analysis software, wireless vital-sign monitors, and external counterpulsation therapy systems.

Headquartered in Plainview, New York, the company operates additional facilities in Tampa, Florida, and Wuxi, China, employing 282 full-time personnel. Its commercial sales team covers 48 contiguous U.S. states, Alaska, and the District of Columbia, while its network services operate across all 50 states. Vaso maintains manufacturing in China and New York, distributing medical devices directly in the United States and China and through independent distributors across international markets.

Summary of the business section of VASO's latest annual report, written by StockData.

Company profile

Company

Legal name
VASO Corp
Founded
1987
Headquarters
Plainview, NY
Address
137 Commercial Street, Ste. 200 11803
Phone
(516) 997-4600
Employees
282, Dec 31, 2025
Industry
Electromedical & Electrotherapeutic Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
UHY LLP, Sterling Heights, Michigan

Stock & identifiers

Ticker
VASO
Exchange
OTC
Shares outstanding
176M, Aug 12, 2026
Public float
$12.80M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
SEC CIK
839087
CUSIP
92233F102
ISIN
US92233F1021
LEI
549300O0FA66XDLHTH45
EIN
11-2871434

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Jun MaChief Exec Officer & President, Director10,498,146
Shaun D. McMeansDirector100,000
Leon DemboDirector150,000

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2024
Jun Ma
$756.64K$756.64K$536.69K$240–
FY2023
Jun Ma
$921.61K$971.61K$585.72K$620–
FY2022
Jun Ma
$805.32K$975.32K$466.63K$340–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we employed 282 full-time persons, of which 15 are employed through our headquarters and VasoMedical facility in Plainview, New York; 109 through VasoHealthcare; 102 through our NetWolves operations; and 56 in our China operations.”

Corporate history

Events identified from SEC filings

DateEventDetails
Jul 31, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Sep 16, 2022Auditor changeChange in certifying accountant (8-K Item 4.01)
May 14, 2021Late filingNotification of late filing
Mar 30, 2021Late filingNotification of late filing
Jun 21, 2019Auditor changeChange in certifying accountant (8-K Item 4.01)
Mar 29, 2019Late filingNotification of late filing
Sep 23, 2016Name changeName changed from VASOMEDICAL, INC to VASO Corp
Jun 4, 2015Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 16, 2014Auditor changeChange in certifying accountant (8-K Item 4.01)
Jul 11, 2014Auditor changeChange in certifying accountant (8-K Item 4.01)
Jul 7, 2014Auditor changeChange in certifying accountant (8-K Item 4.01)
Nov 14, 2012Late filingNotification of late filing
Mar 30, 2012Late filingNotification of late filing
Sep 12, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 26, 2009Auditor changeChange in certifying accountant (8-K Item 4.01)
Mar 19, 2009Auditor changeChange in certifying accountant (8-K Item 4.01)
Jun 5, 2006Auditor changeChange in certifying accountant (8-K Item 4.01)
Jun 1, 2006Auditor changeChange in certifying accountant (8-K Item 4.01)
May 30, 2006Auditor changeChange in certifying accountant (8-K Item 4.01)
May 4, 2006Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Nov 7, 2005Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 4, 2005Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Oct 15, 2002Late filingNotification of late filing
Jan 14, 1999Late filingNotification of late filing
Oct 14, 1997Late filingNotification of late filing
Oct 15, 1996Late filingNotification of late filing